Descheduling

Rescheduling moves cannabis from Schedule I to a lower schedule (like Schedule III) while keeping it within the CSA framework. This would reduce research barriers and eliminate 280E tax penalties but would still maintain federal regulatory control and could introduce FDA drug approval requirements that could conflict with state cannabis markets. Descheduling removes cannabis from the CSA entirely, allowing states to regulate cannabis as they see fit without federal drug scheduling constraints. Most cannabis advocacy organizations support descheduling as the preferred federal policy outcome.

Full descheduling would have sweeping effects: states could regulate cannabis like alcohol without federal conflict, interstate commerce in cannabis could develop, banking access would normalize, Section 280E would become irrelevant, veterans could receive cannabis recommendations from VA doctors, federal employees would no longer face automatic disqualification for cannabis use, and the federal government could develop a comprehensive regulatory framework comparable to alcohol regulation. Descheduling represents the furthest-reaching federal cannabis policy change possible and the ultimate goal of the legalization movement.